Company & Sponsor Intelligence

Baylor College of Medicine

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials11

Recruiting2

Completed8

Countries1

Therapeutic footprint

autismepilepsyother_neurologyparkinsonssubstance_use

Indexed studies

NCT07220161Trigeminal Nerve Stimulation of the Treatment of Epilepsy
epilepsy · United StatesNA

NCT01997255Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
epilepsy · United StatesPHASE2

NCT00691080Understanding Sleep Problems in Children With Autism Spectrum Disorder
autism · United StatesCOMPLETED

NCT01883973MER Versus MRI Guidance DBS in Parkinson's Disease
parkinsons · United StatesCOMPLETED

NCT04111874Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD
autism · United StatesNA

NCT06274164Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders
other_neurology · United StatesRECRUITING

NCT05284435Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD
autism · United StatesNA

NCT03063736Entolimod, an Adjuvant for Vaccine Augmentation
substance_use · United StatesEARLY_PHASE1

NCT03720795Stepped-Care Cognitive-Behavioral Treatment for Youth With ASD and Anxiety
autism · United StatesNA

NCT06046170Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)
autism · United StatesNA

NCT00590122Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study
parkinsons · United StatesPHASE4

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →